Integrated Advisors Network LLC Bio Techne Corp Transaction History

Integrated Advisors Network LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$282.54 - $391.85 $73,177 - $101,489	259 Added 38.26%	936 $266,000
Q2 2022 Aug 12, 2022	BUY	$322.67 - $449.65 $5,808 - $8,093	18 Added 2.73%	677 $235,000
Q1 2022 May 02, 2022	SELL	$353.85 - $487.79 $6,369 - $8,780	-18 Reduced 2.66%	659 $285,000
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $17,333 - $19,952	-38 Reduced 5.31%	677 $350,000
Q2 2021 Aug 06, 2021	SELL	$387.35 - $450.26 $61,976 - $72,041	-160 Reduced 18.29%	715 $322,000
Q1 2021 May 17, 2021	SELL	$314.62 - $411.0 $20,450 - $26,715	-65 Reduced 6.91%	875 $334,000
Q3 2020 Nov 09, 2020	BUY	$232.22 - $282.96 $11,611 - $14,147	50 Added 5.62%	940 $233,000
Q2 2020 Aug 13, 2020	SELL	$185.43 - $279.56 $88,079 - $132,791	-475 Reduced 34.8%	890 $235,000
Q1 2020 May 06, 2020	BUY	$161.17 - $221.51 $11,281 - $15,505	70 Added 5.41%	1,365 $259,000
Q4 2019 Feb 06, 2020	BUY	$189.68 - $222.09 $245,635 - $287,606	1,295 New	1,295 $284,000

616

156M

200K

15.3K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.59B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Integrated Advisors Network LLC, based on Form 13F filings with the SEC.

Stay updated on Integrated Advisors Network LLC with notifications on news.